Külekci Büsra, Schwarz Stefan, Brait Nadja, Perkmann-Nagele Nicole, Jaksch Peter, Hoetzenecker Konrad, Puchhammer-Stöckl Elisabeth, Goerzer Irene
Center for Virology, Medical University of Vienna, Kinderspitalgasse 15, Vienna 1090, Austria.
Department of Thoracic Surgery, Medical University of Vienna, Währinger Gürtel 18-20, Vienna 1090, Austria.
Virus Evol. 2022 Aug 24;8(2):veac076. doi: 10.1093/ve/veac076. eCollection 2022.
Mixed human cytomegalovirus (HCMV) strain infections are frequent in lung transplant recipients (LTRs). To date, the influence of the donor (D) and recipient (R) HCMV serostatus on intra-host HCMV strain composition and viral population dynamics after transplantation is only poorly understood. Here, we investigated ten pre-transplant lungs from HCMV-seropositive donors and 163 sequential HCMV-DNA-positive plasma and bronchoalveolar lavage samples from fifty LTRs with multiviremic episodes post-transplantation. The study cohort included D+R+ (38 per cent), D+R- (36 per cent), and D-R+ (26 per cent) patients. All samples were subjected to quantitative genotyping by short amplicon deep sequencing, and twenty-four of them were additionally PacBio long-read sequenced for genotype linkages. We find that D+R+ patients show a significantly elevated intra-host strain diversity compared to D+R- and D-R+ patients (= 0.0089). Both D+ patient groups display significantly higher viral population dynamics than D- patients (0.0061). Five out of ten pre-transplant donor lungs were HCMV DNA positive, whereof three multiple HCMV strains were detected, indicating that multi-strain transmission via lung transplantation is likely. Using long reads, we show that intra-host haplotypes can share distinctly linked genotypes, which limits overall intra-host diversity in mixed infections. Together, our findings demonstrate donor-derived strains as the main source of increased HCMV strain diversity and dynamics post-transplantation. These results foster strategies to mitigate the potential transmission of the donor strain reservoir to the allograft, such as delivery of HCMV-selective immunotoxins prior to transplantation to reduce latent HCMV.
混合人巨细胞病毒(HCMV)株感染在肺移植受者(LTRs)中很常见。迄今为止,供体(D)和受体(R)的HCMV血清学状态对移植后宿主内HCMV株组成和病毒群体动态的影响仍知之甚少。在此,我们研究了来自HCMV血清阳性供体的10个移植前肺,以及来自50名移植后发生多次病毒血症发作的LTRs的163份连续的HCMV-DNA阳性血浆和支气管肺泡灌洗样本。研究队列包括D+R+(38%)、D+R-(36%)和D-R+(26%)患者。所有样本均通过短扩增子深度测序进行定量基因分型,其中24份样本还进行了PacBio长读长测序以确定基因型连锁。我们发现,与D+R-和D-R+患者相比,D+R+患者的宿主内株多样性显著升高(=0.0089)。两个D+患者组的病毒群体动态均显著高于D-患者(0.0061)。10个移植前供体肺中有5个HCMV DNA呈阳性,其中3个检测到多种HCMV株,这表明通过肺移植进行多株传播是可能的。使用长读长,我们表明宿主内单倍型可以共享明显连锁的基因型,这限制了混合感染中整体宿主内的多样性。总之,我们的研究结果表明供体来源的毒株是移植后HCMV株多样性和动态增加的主要来源。这些结果促进了减轻供体毒株库向同种异体移植物潜在传播的策略,例如在移植前递送HCMV选择性免疫毒素以减少潜伏性HCMV。